PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10893219-4	2000	Maximal IL-8 release was achieved with 10 ng/ml of TGF-beta1 after 16 h of incubation, which was inhibited by the transcription inhibitor actinomycin D and the corticosteroid dexamethasone but was not affected by the nonselective COX inhibitor indomethacin and the selective COX-2 inhibitor NS-398 despite their inhibition on TGF-beta1-induced PGE(2) release.	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	291-297	transforming growth factor beta 1	Homo sapiens	51-60	
20375691-7	2010	Addition of TGF-beta1 reversed inhibition of NS398 in both cell lines.	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	45-50	transforming growth factor beta 1	Homo sapiens	12-21	
20375691-9	2010	These results suggest that TGF-beta1 can increase invasion and reverse inhibition of COX-2 induced by NS398.	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	102-107	transforming growth factor beta 1	Homo sapiens	27-36	
14670842-6	2004	The effect of IL-1beta, BK, and TGF-beta1 on cAMP levels was abrogated by the selective COX-2 inhibitor NS398.	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	104-109	transforming growth factor beta 1	Homo sapiens	32-41	
16837651-6	2007	NS-398 also inhibited the enhancement of alpha-SMA expression by TGF-beta1, IL-1beta, and IL-6 in activated PSCs.	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	0-6	transforming growth factor beta 1	Homo sapiens	65-74	
15288474-4	2004	The effect of NS398, a selective COX-2 inhibitor, and PGE(2) on TGF-beta 1-mediated fibrogenesis was examined by measuring mRNA levels of collagen alpha1(I).	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	14-19	transforming growth factor beta 1	Homo sapiens	64-74	
17302909-9	2007	NS-398, a COX-2 inhibitor, inhibited TGF-beta-induced VEGF production in a dose-dependent manner.	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	0-6	transforming growth factor beta 1	Homo sapiens	37-45